News Articles
Browse our entire archive of news articles, spotlight interviews, and other editorial pieces in one place.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Filters
Tag
Mydecine Reports Second Quarter 2021 Financial Results and Provides Business Update
Mydecine Innovations Group
atai Life Sciences Reports Second Quarter 2021 Financial Results and Business Update
ATAI Life Sciences
Ketamine One Subsidiary KGK Science Secures Multiple New Contracts
Wellbeing Digital Sciences
Filament Health Announces Q2 2021 Financial Results
Filament Health
PsyBio Therapeutics Files Patent Application with USPTO for Production Methods of Methylated Trypatamines and Associated Analogs
PsyBio Therapeutics
MindMed Announces 2021 Q2 Financial Results; Cash Balance of $157 USD Million ($195 CAD Million) to Execute on Diverse Clinical Pipeline
Mind Medicine (MindMed)
Core One Labs’ Clinics Submit Application to Treat Patient With Psilocybin Psychedelic-Assisted Therapy
Core One Labs Inc.
atai Launches Revixia Life Sciences to Develop Salvinorin A for a Variety of Mental Health Conditions
ATAI Life Sciences
Entheon Biomedical Announces Sponsorship of a Clinical Study to Assess the Electroneurophysiologic Effects of Ketamine
Entheon Biomedical
Nova Mentis Files Fragile X Orphan Drug Designation with European Medicines Agency
Nova Mentis Life Science
Philip Young | CEO, Lobe Sciences
Lobe Sciences
Algernon Pharmaceuticals Announces Small Cell Lung Cancer Ifenprodil Research Program and Appoints Dr. William North as Lead Consultant
Algernon Pharmaceuticals
COMPASS Pathways plc announces financial results and business highlights for the second quarter 2021
Compass Pathways
Get the Headlines & Market Updates
Be the first to see new company features, exclusive interviews and breaking news. Subscribe now.